Member Info for 13thmonkey

11am investormeet

It may not be a going first issue, it might just be there needs to be a target for something that there no antibody for, then it would be an affimer Ab race, but there has to be a need that is currently unmet, then we can move onto met in a better way.

animals?

because it's discontinued? and therefore not relevant?

RAH, if the market were not behind the curve then there'd be no opportunities, that's surely what investors do, find the difference between what might happen and what the market thinks, with the size of the 'might' being the risk and the difference being the reward. Unlike traders who are looking at where we are compared to some other view of where the market thinks we are.

I don't like it being a late Friday rns, good or bad it will always look bad.

Guess, or a fact?

2. something complex with many external factors, including a corrupt government and a competing nation state, to contend with did not go according to plan

he cannot be stopped, he cannot be reasoned with, he will kill your finances

It doesn't mean you can't ask questions about things that they have not yet made public, they might not answer, but you can ask.

Unlike 6000, which is doxyrubicin, 3996 is not actual velcade, it's a velcade analogue, so similar but not identical.

so far you've been acting like a twat for all of your time on the board, so that why people treat you like one.
If you'd read or understood anything, then you'd know that the tumours aren't meant to be treated by dox because of the type of study that it is.
If you don't want to be treated like a twat then stop behaving like one, or we will 'ask ourselves why????' and the answer will be that you have an ulterior motive.

I looked over someones shoulder and they have shrunk by 10.

No you f'wit, no one knows because they haven't told us yet, and that wasn't the point of the study anyway.

And your question is almost nonsensical anyway until you mean out of the 10? tumours how many have shrunk, rather than what percentage have they shrunk by.

barc, if you were making a profit then it could be tax advantageous to not have it has income but to have it as investment instead. But we aren't. I'm not concerned about 0.6% dilution. The other issues re: sales i'm more concerned about, BUT I am thinking of leasing as sales.

Nicky what's Ubers mcap, it's losing shed loads, somehow never made a profit of huge revenues.

They are probably limited on implications until later trials. Draw your own conclusions but they can't give you theirs.

Uber are losing a damn site more than that, but have a much higher mcap. Can't even make a profit with a nearly fully depolyed product, which is just software.

That's nearly word for word the motley fool article. With some really weird word choices at the start, 'using their inventory ' ' the agency used'
Pile of junk.

What? Like a refund?

Woland, a tiny tiny bit of caution. I can't do the sums right now, but there is a very high likelihood that we'd get the result that we got and still have 2% chronic, and there is a low likelihood that the 11% acute could still happen, given our sample sizes, essentially we could have gotten lucky with who we picked. I think given all of the other indicators tumour to plasma in particular I think it's likely that the results are truly indicative, and I remain very very confident that I can retire in the next 12months and then probably unretire out of boredom.